gdwl_ex322.htm

EX-32.2 6 gdwl_ex322.htm CERIFICATION gdwl_ex322.htm

EXHIBIT 32.2

SECTION 906 CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

OF GOLDENWELL BIOTECH, INC.

In connection with the accompanying Annual Report on Form 10-K of Goldenwell Biotech, Inc. for the year ended December 31, 2021, the undersigned, Hua Xie, Secretary of Goldenwell Biotech, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

such Annual Report on Form 10-K for the year ended December 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

the information contained in such Annual Report on Form 10-K for the year ended December 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of Goldenwell Biotech, Inc.

Date: February 6, 2023

By:

/s/ Hua Xie

Name: Hua Xie

Title: Secretary (principal accounting officer and principal financial officer)

	(1)	such Annual Report on Form 10-K for the year ended December 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

	(2)	the information contained in such Annual Report on Form 10-K for the year ended December 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of Goldenwell Biotech, Inc.

Date: February 6, 2023	By:	/s/ Hua Xie
		Name: Hua Xie
		Title: Secretary (principal accounting officer and principal financial officer)